Oxford Covid-19 vaccine trial on hold in UK after unexplained illness in volunteer
Published On: Wednesday, September 9, 2020 | By: Team KnowMyStock
AstraZeneca Plc on Tuesday said it has stopped a late-stage trial of one of the leading Covid-19 vaccine candidates after an unexplained illness in a study participant which had reported in the United Kingdom. In a statement issued on Tuesday evening, the company said its "standard review process triggered a pause to vaccination to allow the review of safety data".AstraZeneca didn't reveal any information about the possible side effect except to call it "a potentially unexplained illness".It's likely the unexplained illness was serious enough to require hospitalization and not a mild side effect such as fever or muscle pain, said Deborah Fuller a University of Washington researcher who is working on a different COVID-19 vaccine that has not yet started human trails. The suspension of the trial has impacted other AstraZeneca vaccine trials - as well as clinical trials being conducted by other vaccine makers, which are looking for signs of similar reactions.
Angela Rasmussen, a virologist at Columbia University in New York, tweeted that the illness may be unrelated to the vaccine, "but the important part is that this is why we do trials before rolling out a vaccine to the general public".
We are on Telegram!
JOIN our telegram channel to receive updates on Financial News and Stock and FNO Tips.
Click Here!
Follow Us On:
